MUHAMMAD ZOHAIB KHAN. FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 9, p. 4104–4128, 2024. DOI: 10.53555/vgped651. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/10033. Acesso em: 14 sep. 2025.